KRAS and non-small cell lung carcinoma: We focused on four NSCLC cell lines, two that harbor mutant KRAS but are wild-type for TP53 (A549 and NCI-H460) and two that harbor mutant TP53 but are wild-type for KRAS (NCI-H522 and NCI-H322).